11/07/2024 12:15 PM | Athira Pharma (Subject) BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
10/31/2024 3:16 PM | Athira Pharma (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/28/2024 11:15 PM | Athira Pharma (Filer)
| Form EFFECT | |
10/21/2024 5:24 AM | Athira Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/03/2024 8:50 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4/A | |
10/03/2024 6:07 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 6:08 PM | Athira Pharma (Issuer) Worthington Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
10/03/2024 6:10 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 6:13 PM | Athira Pharma (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 6:17 PM | Athira Pharma (Issuer) Renninger Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 6:05 PM | Athira Pharma (Issuer) Renninger Robert (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/17/2024 8:00 AM | Athira Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 6:47 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:48 PM | Athira Pharma (Issuer) Worthington Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:49 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:50 PM | Athira Pharma (Issuer) Lenington Rachel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:51 PM | Athira Pharma (Issuer) Gengos Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:53 PM | Athira Pharma (Subject) Litton Mark James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:15 PM | Athira Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024 6:21 PM | Athira Pharma (Issuer) Romano Kelly A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 3:05 PM | Athira Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2024 5:54 PM | Athira Pharma (Issuer) FLUKE JOHN M JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 5:55 PM | Athira Pharma (Issuer) PICKERING GRANT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 5:56 PM | Athira Pharma (Issuer) Panzara Michael A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 5:58 PM | Athira Pharma (Issuer) Kosacz Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:00 PM | Athira Pharma (Issuer) JOHNSON JAMES A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:01 PM | Athira Pharma (Issuer) EDELMAN JOSEPH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 6:03 PM | Athira Pharma (Issuer) Romano Kelly A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:34 PM | Athira Pharma (Issuer) San Martin Javier (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/16/2024 3:37 PM | Athira Pharma (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 7:32 AM | Athira Pharma (Filer)
| Form DEF 14A | |
04/09/2024 7:34 AM | Athira Pharma (Filer)
| Form DEFA14A | |
04/09/2024 7:35 AM | Athira Pharma (Filer)
| Form ARS | |
03/28/2024 7:47 AM | Athira Pharma (Filer)
| Form PRE 14A | |
02/22/2024 3:34 PM | Athira Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024 3:15 PM | Athira Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/16/2024 3:46 PM | Athira Pharma (Issuer) Lenington Rachel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:48 PM | Athira Pharma (Issuer) Gengos Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:54 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:32 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4/A | |
02/16/2024 3:34 PM | Athira Pharma (Issuer) Gengos Andrew (Reporting)
| Form 4/A | |
Former Trump advisor releases terrifying warning (Ad) Goldman Sachs: 300 Million People Are At Risk
The mainstream media are practically ignoring the most important financial story of the decade. Goldman Sachs, the IMF, JP Morgan, Bank of America, and Morgan Stanley have issued warnings. Yet most ordinary Americans have no idea. Now one former Trump advisor is sounding the alarm. “If people knew the full facts, there’d be blood in the streets.” Get the facts and learn how to protect your family now. |
02/16/2024 3:37 PM | Athira Pharma (Issuer) Worthington Mark (Reporting)
| Form 4/A | |
02/16/2024 3:38 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4/A | |
02/16/2024 3:40 PM | Athira Pharma (Issuer) Lenington Rachel (Reporting)
| Form 4/A | |
01/08/2024 3:36 PM | Athira Pharma (Issuer) CHURCH KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:38 PM | Athira Pharma (Issuer) Worthington Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:40 PM | Athira Pharma (Issuer) Litton Mark James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:42 PM | Athira Pharma (Issuer) Gengos Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:45 PM | Athira Pharma (Issuer) MOEBIUS HANS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:35 PM | Athira Pharma (Issuer) Lenington Rachel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 6:11 AM | Athira Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 4:24 PM | Athira Pharma (Issuer) EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:15 PM | Athira Pharma (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |